Left Main Percutaneous Coronary Revascularization

Average (ratings)

No ratings

•

Your rating

In this episode of the Radcliffe Podcast, we are joined by Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA), Dr Khalid AlJohani (King Saud University, SA), and Dr Abdulrahman AlMoghairi (Prince Sultan Cardiac Center, SA) as they discuss methods and approaches to left main percutaneous coronary revascularization.

In this podcast, Dr Alasnag, Dr AlJohani and Dr AlMoghairi discuss the current guidelines for left main PCI, the techniques they use to position and optimise left main ostial stents, and intracoronary imaging to assist stent placement in the left main artery. They also discuss recent research into left main PCI, including the conflicting results of the EBC Main and DK Crush V trials. Dr AlMoghairi then outlines his thoughts towards mechanical circulatory support in left main stenting. Finally, Dr Alasnag, Dr AlJohani and Dr AlMoghairi discuss the gaps in knowledge and opportunities for future research, including operator training and geographic differences in left main PCI.

What are the latest developments in left main percutaneous coronary intervention? Where are the knowledge gaps?

Prefer to watch in video format? Click here.

If you have any questions or suggestions, please email managingeditor@ecrjournal.com.

Read MoreRead Less

Audio Video

Episodes

Up Next

View from the Thoraxcenter: ESC 23 Late-breaking Science Preview

EP26 • Aug 10, 2023 • 33m

In this episode of View of the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) preview the hot line and late-breaking data presented at ESC Congress 2023. With their dynamic analysis, they place these highly anticipated trials within a context, highlighting the real-world implications tied to the data releases.

All Episodes

Targeting Inflammation in Atherosclerosis: LoDoCo2 Trial

EP8 • Apr 22, 2022 • 5m 3s

In this LoDoCo2 presentation, Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) covers the trial design and main results.

Supported by an unrestricted educational grant from NOVO NORDISK A/S.

Targeting Inflammation in Atherosclerosis: RESCUE Trial

EP7 • Apr 12, 2022 • 4m 22s

Join Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) as he talks us through the RESCUE trial design and results in this short podcast.

Targeting Inflammation in Atherosclerosis: CANTOS Trial

EP6 • Apr 12, 2022 • 6m 19s

Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) provides us with an overview of the CANTOS main trial results and updated results from the ACC 2022.

Ep 5: Invasive Diagnosis of Coronary Functional Disorders Causing Angina Pectoris

EP5 • Mar 25, 2022 • 29m 28s

Did you know that coronary vasomotion disorders are a frequent cause of angina in patients with non-obstructed coronary arteries? In this month's episode of the ECR podcast, Dr Andreas Seitz and Dr Peter Ong (Robert-Bosch Hospital, Stuttgart, DE) return to discuss their recent article on the diagnosis of coronary disorders which cause angina (https://www.ecrjournal.com/articles/invasive-diagnosis-coronary-functional-disorders-causing-angina-pectoris) from ECR Journal.

Ep 4: The EXCEL Trial: The Interventionalists’ Perspective

EP4 • Jan 28, 2022 • 12m 40s

In this month's featured author episode of the ECR Podcast, interventional fellow Dr George Hunter (Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK) discusses the EXCEL trial from his perspective as a member of the PCI community, based on a recent review paper from the ECR Journal. In this podcast, Dr Hunter discusses the controversy surrounding the trial and the importance of studying left main stem disease in cardiology today.

Ep 3: Atrial Fibrillation in Congenital Heart Disease

EP3 • Nov 30, 2021 • 16m 52s

Did you know that atrial arrhythmias are the most common complication in adults with congenital heart disease?

Dr Irene Martin de Miguel (Hospital General Universitario Gregorio Marañón, Madrid, Spain) joins us in this featured author episode to outline her recent review article, Atrial Fibrillation in Congenital Heart Disease. In this podcast, Dr de Miguel provides an overview of the current knowledge of AF in CHD, giving practical recommendations for your everyday practice.

Ep 2: Prognostication of patients with coronary stenoses: pre-and post-PCI

EP02 • Oct 29, 2021 • 20m 38s

Is there enough evidence to support the prognostic value of coronary physiology measurements in pre-and post-PCI settings? Is post-PCI FFR ready for clinical practice?

Today's episode features co-hosts Dr Peter Ong and Dr Andreas Seitz (Robert-Bosch Hospital, Stuttgart, DE) who together summarise the main results from the TARGET FFR and DEFINE-FLOW trials that were presented at TCT Connect 2020 and published recently in ECR journal, in the context of the existing literature.

Ep 1: Women and Heart Disease

EP1 • Oct 01, 2021 • 44m 44s

Did you know that CV disease is the leading cause of death in women and that women are more likely to die of heart disease compared to men? Dr Erin Michos (John Hopkins Uni, US) and Dr Martha Gulati (Uni of Arizona, US) join us on the inaugural episode of the ECR podcast series to discuss issues surrounding women in heart disease. Together they explore a variety of topics that are addressed in the latest special focus issue in the European cardiology Review journal.

1 2 3 4

... 2 3 4

View from the Thoraxcenter: EuroPCR 24 Preview

EP33 • May 07, 2024 • 26m 3s

Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.

View from the Thoraxcenter: ACC.24 Wrap Up

EP32 • Apr 15, 2024 • 43m 48s

Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC.24.

View from the Thoraxcenter: ACC.24 Late-breaking Science Preview

EP31 • Mar 25, 2024 • 28m 10s

What’s hot at ACC.24?

Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.

VHPSD versus Conventional Catheter Ablation in AF

Very-High Power Short Duration Vs Conventional Ablation for PVI in AF

EP30 • Dec 14, 2023 • 29m 53s

In this episode of the Radcliffe Podcast, we are joined by Dr Raymond Pranata, Dr Mohammad Iqbal and Dr Giky Karwiky (Hasan Sadikin General Hospital, Bandung, Indonesia) as they discuss their recently published systematic review and meta-analysis of very-high-power short-duration ablation as compared to conventional ablation for the treatment of pulmonary vein isolation in atrial fibrillation.

View from the Thoraxcenter: AHA 23 Wrap Up

View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

EP29 • Nov 20, 2023 • 23m 14s

Join Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) as they review the latest late-breaking science data from AHA Scientific Sessions 2023.
They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.

1 2 3 4 5 6 ...

1 2 3 ...